Free Trial

SIGA Technologies (SIGA) Competitors

SIGA Technologies logo
$6.32 +0.11 (+1.69%)
Closing price 03:59 PM Eastern
Extended Trading
$6.28 -0.04 (-0.63%)
As of 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SIGA vs. INDV, APGE, IRON, BHC, BEAM, ARQT, BHVN, SDGR, EWTX, and JANX

Should you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Indivior (INDV), Apogee Therapeutics (APGE), Disc Medicine (IRON), Bausch Health Companies (BHC), Beam Therapeutics (BEAM), Arcutis Biotherapeutics (ARQT), Biohaven (BHVN), Schrödinger (SDGR), Edgewise Therapeutics (EWTX), and Janux Therapeutics (JANX). These companies are all part of the "pharmaceutical products" industry.

SIGA Technologies vs.

Indivior (NASDAQ:INDV) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings, valuation and community ranking.

SIGA Technologies has a net margin of 49.33% compared to Indivior's net margin of -3.96%. SIGA Technologies' return on equity of 49.06% beat Indivior's return on equity.

Company Net Margins Return on Equity Return on Assets
Indivior-3.96% -241.73% 15.09%
SIGA Technologies 49.33%49.06%38.72%

Indivior currently has a consensus price target of $15.00, suggesting a potential upside of 10.05%. Given Indivior's stronger consensus rating and higher possible upside, equities research analysts plainly believe Indivior is more favorable than SIGA Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Indivior
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
SIGA Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Indivior had 4 more articles in the media than SIGA Technologies. MarketBeat recorded 7 mentions for Indivior and 3 mentions for SIGA Technologies. SIGA Technologies' average media sentiment score of 1.60 beat Indivior's score of 1.35 indicating that SIGA Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Indivior
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SIGA Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Indivior has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.

60.3% of Indivior shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 2.0% of SIGA Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Indivior received 6 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 100.00% of users gave Indivior an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.

CompanyUnderperformOutperform
IndiviorOutperform Votes
11
100.00%
Underperform Votes
No Votes
SIGA TechnologiesOutperform Votes
5
23.81%
Underperform Votes
16
76.19%

SIGA Technologies has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Indivior$1.17B1.61$2M-$0.31-43.97
SIGA Technologies$120.33M3.76$68.07M$0.679.44

Summary

SIGA Technologies beats Indivior on 10 of the 19 factors compared between the two stocks.

Get SIGA Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

MetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$451.15M$6.86B$5.58B$8.61B
Dividend YieldN/A2.49%5.27%4.19%
P/E Ratio5.268.8427.2920.07
Price / Sales3.76257.85410.86158.91
Price / Cash6.3465.8538.2534.64
Price / Book2.286.597.124.71
Net Income$68.07M$143.71M$3.23B$247.80M
7 Day Performance2.85%4.13%2.99%2.30%
1 Month Performance11.75%14.38%12.39%9.55%
1 Year Performance-19.53%5.31%31.73%14.92%

SIGA Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
SIGA Technologies
2.575 of 5 stars
$6.33
+1.7%
N/A-20.1%$451.15M$120.33M5.2640Positive News
INDV
Indivior
1.984 of 5 stars
$12.46
-3.1%
$15.00
+20.4%
-19.3%$1.72B$1.17B-35.601,164Positive News
APGE
Apogee Therapeutics
2.0557 of 5 stars
$36.33
-0.8%
$94.60
+160.4%
-4.3%$1.67BN/A-15.0191
IRON
Disc Medicine
1.8605 of 5 stars
$47.73
+2.2%
$98.80
+107.0%
+33.6%$1.65BN/A-11.9930Positive News
Analyst Forecast
Insider Trade
Analyst Revision
BHC
Bausch Health Companies
4.5745 of 5 stars
$4.49
-1.0%
$7.42
+65.4%
-19.5%$1.64B$9.73B-37.3719,900Positive News
BEAM
Beam Therapeutics
3.0457 of 5 stars
$16.19
+2.3%
$48.75
+201.1%
-25.9%$1.63B$63.58M-9.20510Analyst Revision
ARQT
Arcutis Biotherapeutics
2.0066 of 5 stars
$13.48
+3.4%
$18.80
+39.5%
+84.2%$1.61B$212.82M-7.53150Positive News
BHVN
Biohaven
2.7911 of 5 stars
$15.62
+5.4%
$59.46
+280.8%
-52.2%$1.59BN/A-1.67239Analyst Revision
High Trading Volume
SDGR
Schrödinger
1.5661 of 5 stars
$21.69
+0.3%
$32.80
+51.2%
+22.4%$1.59B$230.49M-9.27790
EWTX
Edgewise Therapeutics
3.1058 of 5 stars
$14.69
+2.9%
$40.22
+173.8%
-9.8%$1.55BN/A-9.7960
JANX
Janux Therapeutics
1.5855 of 5 stars
$25.01
+5.1%
$95.25
+280.8%
-39.5%$1.48B$9.34M-21.3830Positive News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:SIGA) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners